Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Mar. 2025,
JMI Syringes & Medical Devices paidBDT0 Mil more to buy back shares than it received from issuing new shares.
It receivedBDT37 Mil from issuing more debt.
It paidBDT0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It spentBDT26 Mil paying cash dividends to shareholders.
It spentBDT1 Mil on other financial activities.
In all, JMI Syringes & Medical DevicesearnedBDT10 Mil on financial activities for the
three
months ended in Mar. 2025.
JMI Syringes & Medical Devices (DHA:JMISMDL) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
JMI Syringes & Medical Devices's issuance of stock for the
three
months ended in Mar. 2025 was BDT0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
JMI Syringes & Medical Devices's repurchase of stock for the
three
months ended in Mar. 2025 was BDT0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
JMI Syringes & Medical Devices's net issuance of debt for the
three
months ended in Mar. 2025 was BDT37 Mil.
JMI Syringes & Medical Devices receivedBDT37 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
JMI Syringes & Medical Devices's net issuance of preferred for the
three
months ended in Mar. 2025 was BDT0 Mil.
JMI Syringes & Medical Devices paidBDT0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
JMI Syringes & Medical Devices's cash flow for dividends for the
three
months ended in Mar. 2025 was BDT-26 Mil.
JMI Syringes & Medical Devices spentBDT26 Mil paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
JMI Syringes & Medical Devices's other financing for the
three
months ended in Mar. 2025 was BDT-1 Mil.
JMI Syringes & Medical Devices spentBDT1 Mil on other financial activities.
JMI Syringes & Medical Devices Cash Flow from Financing Related Terms
JMI Syringes & Medical Devices Cash Flow from Financing Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMI Syringes & Medical Devices Cash Flow from Financing Chart
JMI Syringes & Medical Devices Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-26 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of BDT-26 Mil mean?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a Cash Flow from Financing of BDT-26 Mil as of Mar. 2025. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for JMI Syringes & Medical Devices and its competitors.
Is JMI Syringes & Medical Devices' Cash Flow from Financing too high?
JMI Syringes & Medical Devices' current Cash Flow from Financing is BDT-26 Mil. Overall, JMI Syringes & Medical Devices has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does JMI Syringes & Medical Devices' Cash Flow from Financing compare to ISRG and BDX?
JMI Syringes & Medical Devices' Cash Flow from Financing of BDT-26 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Medical Devices & Instruments company?
A good Cash Flow from Financing depends on the Medical Devices & Instruments industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for JMI Syringes & Medical Devices and its competitors. JMI Syringes & Medical Devices's current Cash Flow from Financing is BDT-26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Syringes & Medical Devices stock overvalued right now?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a current Cash Flow from Financing of BDT-26 Mil. The current Cash Flow from Financing is BDT-26 Mil. JMI Syringes & Medical Devices' overall GF Score™ is 75/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For JMI Syringes & Medical Devices (DHA:JMISMDL), the current Cash Flow from Financing is BDT-26 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
JMI Syringes & Medical Devices Ltd is a Bangladesh-based syringe and medical device manufacturing company. It manufactures and markets disposable syringe, auto-disable syringe, needle, infusion set, scalp vein set, urine drainage bag, insulin syringe, First AID bandage, riles tube, IV Cannula, feeding tube, and Blood Lancets, and other products.
75GF Score
Get the complete analysis for DHA:JMISMDL
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:JMISMDL has been successfully added to your 
